INS and metabolic disease: The metabolic disorders of these intermediates can lead to conditions such as intestinal inflammation (Connors et al., 2018), cancer, insulin secretion, histone acetylation, neurological diseases, and NAFLD (Iacobazzi and Infantino, 2014).